← Back to All Industries
Medical Devices
Comprehensive biological safety strategy, ISO 10993-18 chemical characterization, simulated-use study coordination, and ISO 14971 risk management integration for medical device manufacturers.
Sector Demands
Typical Industry Requirements
•Chemical characterization aligned with ISO 10993-18 and FDA guidance
•Biological Evaluation Plan (BEP) and Biological Evaluation Report (BER)
•Toxicological assessment coordination per ISO 10993-17 (TI/TE, Margin of Safety)
•Simulated-use and exaggerated extraction study execution
•Integration of chemical characterization data into ISO 14971 risk management files
Our Technical Scope
Relevant SG Pharma Solutions Capabilities
✓Constituent material assessment for polymers, elastomers, metals, and adhesives
✓Analytical Evaluation Threshold (AET) calculation based on patient contact duration
✓Coordination of solvent extraction and LC-MS / GC-MS / ICP-MS profiling with partner labs
✓Definitive toxicological risk evaluations for detected leachables
✓Technical authoring support for 510(k), PMA, and EU MDR CE technical documentation
Structured Collaboration
Typical Engagement Pathway
1
Biological Evaluation Planning (BEP)2
Chemical Characterization Strategy & Testing3
Toxicological Threshold Evaluation (ISO 10993-17)4
Risk Management File Integration (ISO 14971)5
Biological Evaluation Report (BER) AuthoringRelevant Laboratory Products
Direct Enquiry
Ready to Discuss Your Project?
Submit your technical requirements or product sourcing needs. Our technical team will review your specifications promptly.
Request Consultation →